FDA Brief

Warning letters Drugs

FDA warning letter to

Tager Online, Inc. DBA Volt Candy; Volt Candy Wholesale Club

High riskIssued Apr 27, 2023Posted May 2, 2023Center for Drug Evaluation and Research | CDER

FDA warned Volt Candy that PrimeZEN Black 6000, sold as a supplement, contained undeclared tadalafil and sildenafil and was an unapproved, misbranded drug.

What happened

FDA reviewed www.voltcandy.com, two redirecting websites, and a Facebook page between December 2022 and March 2023, where Volt Candy took orders for PrimeZEN Black 6000. FDA also obtained a sample and labeling, and laboratory analysis found undeclared tadalafil and sildenafil. The letter notes the product was recalled in February 2023 and is no longer offered on the website.

What FDA found

  1. The product is an unapproved new drug because FDA has not approved it and it is not generally recognized as safe and effective for its claimed uses.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. The label lacks adequate directions for use, and the product is a prescription drug that cannot be safely used without a licensed practitioner.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1); 21 CFR 201.5
  3. The label is false or misleading because it does not declare that the product contains tadalafil and sildenafil.

    FD&C Act sections 502(a) and 201(n), 21 U.S.C. 352(a) and 321(n)
  4. The label lacks adequate warnings for users, despite serious risks from the undeclared drug ingredients.

    FD&C Act section 502(f)(2), 21 U.S.C. 352(f)(2)
  5. The product cannot be a dietary supplement because tadalafil and sildenafil were not marketed as supplements or food before FDA approved them as drugs.

    FD&C Act section 201(ff)(3)(B)(i), 21 U.S.C. 321(ff)(3)(B)(i)
  6. Shipping or selling this misbranded drug across state lines is prohibited.

    FD&C Act section 301(a), 21 U.S.C. 331(a)

What FDA wants

Submit a written response within fifteen working days from receipt explaining the specific steps taken to address the violations and prevent recurrence, with supporting documentation. If you believe the product is not in violation, include your reasoning and supporting information.

Who should pay attention

  • retailers and online sellers of male enhancement supplements
  • brands that buy or distribute products from Volt Candy
  • consumers who take nitrates or have heart disease, diabetes, or high blood pressure

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  2. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk